Corrigendum to “Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay” [Bioorg. Med. Chem. Lett. 25 (2015) 2505–2509]
Publication date
2016-08-01
Authors
Arns, Steve
Tan, Jason
Sun, Sharon
Galey, Adam
Zisman, Natalia
Ross, Fiona
Udechukwu, Jenna
Dercho, Samantha
Gusti, Vionarica
Paquette, Jay
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
No license information available
Abstract
When this Letter was first published the author, Tom Wennekes, was omitted from the authorship list. The correct authorship is printed above.
Keywords
Taverne, Biochemistry, Molecular Medicine, Molecular Biology, Pharmaceutical Science, Drug Discovery, Clinical Biochemistry, Organic Chemistry
Citation
Arns, S, Tan, J, Sun, S, Galey, A, Zisman, N, Ross, F, Udechukwu, J, Dercho, S, Gusti, V, Paquette, J, Wennekes, T, Webb, M, Bourque, E, Withers, S G & Liggins, R 2016, 'Corrigendum to “Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay” [Bioorg. Med. Chem. Lett. 25 (2015) 2505–2509]', Bioorganic and Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3830. https://doi.org/10.1016/j.bmcl.2016.06.068